40 employees
Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases.
2020
$56M
from 2 investors over 2 rounds
Longboard Pharmaceuticals raised $56M on October 28, 2020
Investors: T. Rowe Price and Farallon Capital Management